Macrophage-supported metabolic adaptation drives tumor survival under nutrient stress
Authors:
- Nancy T. SantiappillaiNSNancy T. Santiappillai
- Andrew ChoACAndrew Cho
- Georg VerchGVGeorg Verch
- Ana C. CodoACAna C. Codo
- Achuth NairANAchuth Nair
- Ya-Ting WangYWYa-Ting Wang
- Allie LipshutzALAllie Lipshutz
- Celia Martínez de la TorreCTCelia Martínez de la Torre
- Eric Minwei LiuELEric Minwei Liu
- Alissa J. TrzeciakATAlissa J. Trzeciak
- Zhaoquan WangZWZhaoquan Wang
- 2 October 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (40)
Abstract
Triple-negative breast cancer (TNBC) develops in hypoxic, nutrient-limited tumors enriched with macrophages and cell death. We show that metabolically distinct TNBCs differentially exploit macrophage-derived nutrients, influencing tumor growth and therapeutic response. Prolonged hypoxia reprogrammed mouse and human macrophages, enabling them to release metabolites that rescued the growth of select TNBC cell lines during glutamine deprivation or glutamine metabolism inhibition. Hypoxic macrophages reduced glutamine consumption, increased arginine utilization, and secreted higher levels of ornithine, an intermediate of arginine metabolism. Exogenous ornithine, but not arginine, restored the growth of responsive TNBC cells. Mechanistically, TNBC cells diverted ornithine into proline biosynthesis, supporting oxidative pentose phosphate pathway activity. In vivo, depletion of tumor-associated myeloid cells reduced tumor growth and impaired proline synthesis in glutaminase inhibitor–resistant TNBC. These findings identify hypoxia-driven metabolic cross-talk between macrophages and TNBC cells, revealing ornithine-dependent proline metabolism as a mechanism by which macrophages sustain tumor growth under nutrient stress and contribute to resistance to glutamine-targeted therapies.Keywords
Funding Information
- National Institutes of Health (NCI 5R00CA237728)
- National Institutes of Health (NIGMS 1DP2GM146337)
- National Institutes of Health (R01CA237466)
- National Institutes of Health (R01CA252037)
- National Institutes of Health (R01CA248364)
- National Institutes of Health (R01CA249294)
- National Institutes of Health (R01CA283578)
- National Institutes of Health (F30CA225174)
- American Heart Association (25PRE1363345)
- National Institutes of Health (5T32AI134632)
- National Institutes of Health (F31HL182129)
- Pew Charitable Trusts (Biomedical Scholars Award)
- American Cancer Society (Research Scholar Grant)
- Damon Runyon Cancer Research Foundation (Rachleff Innovator Award)
- Fiona and Stanley Druckenmiller Center for Lung Cancer Research
- Howard Hughes Medical Institute (Gilliam Fellowship)
- V Foundation for Cancer Research
- Center for Molecular Imaging and Bioengineering
- The Mark Foundation (Aspire I award)
- Tow Foundation and the Experimental Therapeutics Center
- MSK Cancer Center (P30CA008748)
This publication has 57 references indexed in Scilit:
- Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistanceCancer Cell, 2024
- Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growthCell Metabolism, 2023
- Metabolic adaptation supports enhanced macrophage efferocytosis in limited-oxygen environmentsCell Metabolism, 2022
- Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancerCell Reports, 2022
- Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic CancerCell Metabolism, 2019
- Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of CancerCell, 2018
- In Vivo Imaging of Glutamine Metabolism to the Oncometabolite 2-Hydroxyglutarate in IDH1/2 Mutant TumorsCell Metabolism, 2017
- The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4Cell, 2013
- Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor GrowthCancer Cell, 2012
- Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumorsNMR in Biomedicine, 2012